BioMarin Pharmaceutical (BMRN)
(Delayed Data from NSDQ)
$75.90 USD
-0.55 (-0.72%)
Updated May 23, 2024 04:00 PM ET
After-Market: $75.91 +0.01 (0.01%) 7:58 PM ET
3-Hold of 5 3
C Value F Growth A Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
07/29/2024
Time: -- |
6/2024 | $0.57 | -1.83% |
Earnings Summary
For their last quarter, BioMarin Pharmaceutical (BMRN) reported earnings of $0.71 per share, beating the Zacks Consensus Estimate of $0.60 per share. This reflects a positive earnings surprise of 18.33%. Look out for BMRN's next earnings release expected on July 29, 2024. For the next earning release, we expect the company to report earnings of $0.57 per share, reflecting a year-over-year increase of 5.56%.
Earnings History
Price & Consensus
Zacks News for BMRN
5 Biotech Stocks Worth Adding to Your Portfolio in 2024
BMRN: What are Zacks experts saying now?
Zacks Private Portfolio Services